Suspended PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT02460484

Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke

Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal

Sponsor: Cord Blood Registry, Inc.

Conditions Perinatal Arterial Ischemic Stroke

Interventions Autologous Cord Blood Infusion

Updated 9 times since 2017 Last updated: Mar 16, 2022 Started: Apr 30, 2015 Primary completion: Jun 30, 2022 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Restructuring Cell Lab

A PHASE1/PHASE2 clinical study on Perinatal Arterial Ischemic Stroke, this trial is suspended. The trial is conducted by Cord Blood Registry, Inc. and has accumulated 9 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Suspended PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Suspended PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Apr 2022 — Jul 2024 [monthly]

Suspended PHASE1_PHASE2
Jan 2021 — Apr 2022 [monthly]

Suspended PHASE1_PHASE2
May 2020 — Jan 2021 [monthly]

Suspended PHASE1_PHASE2

▶ Show 4 earlier versions

Jun 2018 — May 2020 [monthly]

Suspended PHASE1_PHASE2
Mar 2018 — Jun 2018 [monthly]

Suspended PHASE1_PHASE2
Feb 2017 — Mar 2018 [monthly]

Suspended PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Suspended PHASE1_PHASE2

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cord Blood Registry, Inc.
James Baumgartner, MD

Data source: AdventHealth

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orlando, United States